Calcium channel blockers (CCBs) are recommended in international and national guidelines for management of hypertension

UK NICE Guidelines 2007 for the management of hypertension

CCBs are a recommended first-line antihypertensive treatment option in the majority of international and national clinical guidelines.1-8 CCBs may be used to initiate either monotherapy or combination therapy for hypertension.1

The UK NICE guidelines for management of hypertension recommend CCBs as a first-line hypertension treatment in people aged ≥55 years and in black people of African or Caribbean family origin of any age.2

CCBs are also recommended in combination therapy to improve BP control.1,3,5-8


  1. Mancia G, et al. Eur Heart J. 2013 Jul;34(28):2159-219.
  2. NICE clinical guidelines. Available at:
  3. Chiang CE, et al. J Formas Med Assoc 2010;109:740-73.
  4. Park JB. Korean Circulation J 2006;36:405-10.
  5. Flack JM, et al. Hypertension 2010;56:780-800.
  6. Canadian Hypertension Education Programm [Internet]. Available from: Accessed 15th February 2018.
  7. James PA, et al. JAMA. doi:10.1001/Jama.2013.284427.
  8. Liu LS, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579-615.